Allscripts Healthcare Solutions is in the technology sector and application software industry. The company CEO is Paul M. Black. Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.
Previous Intraday Trading Performance:
The MDRX stock showed a previous change of 3.70% with an open at 10.06 and a close of 10.37. It reached an intraday high of 10.38 and a low of 10.06.
The stock has a market cap of $1.7b with 166.4m shares outstanding, of which the float is 155.8m shares. Trading volume reached 1,753,445 shares compared to its average volume of 1,681,512 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.
Historical Trading Performance:
Over the last five trading days, Allscripts Healthcare Solutions shares returned 1.97% and in the past 30 trading days it returned 7.46%. Over three months, it changed -2.81%. In one year it has changed -18.35% and within that year its 52-week high was 14.97 and its 52-week low was 8.54. MDRX stock is 21.43% above its 52 Week Low.
Our calculations show a 200 day moving average of 11.42 and a 50 day moving average of 9.92. Currently MDRX stock is trading -9.21% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.
The last annual fiscal EPS for the company was reported at 2.04 that ended on 31st of December 2018, which according to the previous close, that is a PE of 5.08. Based on 10 analyst estimates, the consensus EPS for the next quarter is 0.11. The TTM EPS is 0.53, which comes to a TTM PE of 19.57.
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr of 2019||(Reported on 05/02/2019):||-0.04|
|4th||Qtr of 2018||(Reported on 02/21/2019):||2.14|
|3rd||Qtr of 2018||(Reported on 11/01/2018):||-0.20|
|2nd||Qtr of 2018||(Reported on 08/02/2018):||0.36|
|1st||Qtr of 2018||(Reported on 05/03/2018):||-0.22|
Base on our calculations, the intrinsic value per share is 10.62, which means it is possibly undervalued and has a margin of safety of 2.39%.
Indicators to Watch:
The current calculated beta is 1.21.
SeekingAlpha: Douglas Emmett reports Q1 results
Based on last reported financials, the company’s return on equity is 32.57%, return on assets is 10.97%, profit margin is 22.29%, price-to-sales is 0.87 and price-to-book is 1.14.
All scores are out of six:
1 :Valuation Score
1 :Past Performance Score
1 :Financial Strength Score
3 :Future Growth Score
0 :Dividend Score
1 :Overall Score